Literature DB >> 2007924

Safety of casein hydrolysate formula in children with cow milk allergy.

H A Sampson1, J Bernhisel-Broadbent, E Yang, S M Scanlon.   

Abstract

The purpose of this study was to determine whether a new casein hydrolysate infant formula, Alimentum, could be administered safely to children with cow milk hypersensitivity. The formula was analyzed by sodium dodecyl sulfate-polyacrylamide gel electrophoresis and with a sensitive enzyme-linked inhibition immunoassay, and it was judged to be safe for clinical trials in children allergic to cow milk. Twenty-five such children underwent double-blind placebo-controlled oral food challenges with 10 gm of powdered cow milk and casein hydrolysate formula. All children were highly atopic and had positive skin prick reactions to cow milk. No patient reacted to placebo during a double-blind, placebo-controlled food challenge. Two patients lost their allergy to cow milk and did not react during the challenge; the remaining patients reacted with a variety of cutaneous, respiratory, and gastrointestinal symptoms within 15 to 90 minutes of challenge. All children tolerated the blinded challenge to the casein hydrolysate and were fed the hydrolysate openly without difficulty. We conclude that this casein hydrolysate is generally safe to feed to children with immediate hypersensitivity to cow milk. We recommend that all infant formulas promoted as "hypoallergenic" be tested in milk-allergic patients to assess their allergenic potential, in addition to standard nutritional evaluation and animal testing for antigenicity.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2007924     DOI: 10.1016/s0022-3476(05)90001-2

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  23 in total

Review 1.  Risk factors for the development of food allergy.

Authors:  Ujwala Kaza; Adina Kay Knight; Sami L Bahna
Journal:  Curr Allergy Asthma Rep       Date:  2007-06       Impact factor: 4.806

Review 2.  Strategies for prevention.

Authors:  Y Vandenplas
Journal:  Clin Rev Allergy Immunol       Date:  1995       Impact factor: 8.667

3.  Partially hydrolyzed whey formula intolerance in cow's milk allergic patients.

Authors:  Maureen Egan; Tricia Lee; Jade Andrade; Galina Grishina; Michelle Mishoe; Gustavo Gimenez; Hugh A Sampson; Supinda Bunyavanich
Journal:  Pediatr Allergy Immunol       Date:  2017-06       Impact factor: 6.377

4.  Treatment and prevention of milk allergy.

Authors:  S P Galant
Journal:  West J Med       Date:  1993-06

5.  Criteria for labelling infant formulas as "hypoallergenic". Allergy Section, Canadian Pediatric Society.

Authors: 
Journal:  CMAJ       Date:  1994-03-15       Impact factor: 8.262

6.  Hypo-allergenic formulae: what's in a name?

Authors:  J P Buts; S Cadranel; A Deprettere; M Scaillon; E Sokal; M Van Caillie-Bertrand; Y Vandenplas; M Vanwinckel
Journal:  Eur J Pediatr       Date:  1994-05       Impact factor: 3.183

7.  Allergenicity of milk protein hydrolysate formulae in children with cow's milk allergy.

Authors:  V Ragno; P G Giampietro; G Bruno; L Businco
Journal:  Eur J Pediatr       Date:  1993-09       Impact factor: 3.183

Review 8.  Approach to milk protein allergy in infants.

Authors:  Herbert Brill
Journal:  Can Fam Physician       Date:  2008-09       Impact factor: 3.275

9.  Characterization of antigens and allergens in hypo-allergenic infant formulae.

Authors:  I Görtler; R Urbanek; J Forster
Journal:  Eur J Pediatr       Date:  1995-04       Impact factor: 3.183

10.  Safety evaluation of a food enzyme containing trypsin and chymotrypsin from porcine pancreas.

Authors:  Claude Lambré; José Manuel Barat Baviera; Claudia Bolognesi; Pier Sandro Cocconcelli; Riccardo Crebelli; David Michael Gott; Konrad Grob; Evgenia Lampi; Marcel Mengelers; Alicja Mortensen; Gilles Rivière; Inger-Lise Steffensen; Christina Tlustos; Henk Van Loveren; Laurence Vernis; Holger Zorn; Ursula Gundert-Remy; Lieve Herman; Dominique Turck; Karl-Heinz Engel; Margarita Aguilera-Gómez; Magdalena Andryszkiewicz; Natalia Kovalkovicova; Yi Liu; Joaquim Maia; Sandra Rainieri; Andrew Chesson
Journal:  EFSA J       Date:  2021-06-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.